Zucara Therapeutics zucara.ca


Public lists: Pharma Startups (6570)

Zurcara Therapeutics is developing a drug therapy to prevent hypoglycemia in people with diabetes. The Company's therapeutic is aimed at inhibiting a hormone in the pancreas called somatostatin, which does not function properly in diabetes.

Zurcara Therapeutics is developing a drug therapy to prevent hypoglycemia in people with diabetes. The Company's therapeutic is aimed at inhibiting a hormone in the pancreas called somatostatin, which does not function properly in diabetes.

Company (Alive / Active)

Phone:

Fax:

1300-661 University Avenue

Toronto, M5G 0B7
Ontario, Canada

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Zucara Therapeutics $25.8M Mar 31, 2020

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Zucara Therapeutics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
JLabsIncubator/AcceleratorSan Diego, California, United StatesIncubator/Accelerator
Accel-Rx Health Sciences AcceleratorIncubator/AcceleratorVancouver, British Columbia, CanadaSeed
Centre for Drug Research & DevelopmentCorporationVancouver, British Columbia, CanadaConvertible Note, Seed, Spinoff / Spinout
GlycoNetNon-Profit FoundationNisku, Alberta, CanadaGrant - III
See all 10 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)